Foresite Capital
Venture capitalLarkspur · Pre-Seed–Late Stage · 59 people tracked
Also known as FORESITE CAPITAL MANAGEMENT, LLC
Investment thesis
Foresite Capital pursues breakthrough opportunities at the intersection of technology and biotech, backed by a deeply technical investment team. Its thesis-driven process systematically identifies key trends driving change in healthcare and life sciences. The firm invests across multiple stages, funding promising businesses throughout their life cycles, and uses a data science-driven methodology to identify companies that combine biology and big data to address areas of significant unmet medical need and transform healthcare.
Source: firm website, verified Aug 3, 2026.
Team · 59 people
from the firm's website & public directories
What they invest in
from 87 of 223 portfolio companiesBiotech ×69Healthtech ×34Medical Devices ×25Digital Health ×15AI & Machine Learning ×13Deep Tech ×5Enterprise Software ×3Data & Infrastructure ×2
HQs:United States×72Denmark×1United Kingdom×1
Investments · 223 tracked
founders shown can be your intro pathSouth San Francisco, US
Board seatJames Tananbaum· per SEC Form D · $40M raise · filed Jul 2024
BiotechHayward, US
Roger M. Perlmutter(Executive Officer, Director)Adam Goulburn(Director)
BoardJoshua Wolfe(Director)Dror Berman(Director)Leon Chen(Director)
Board seatJames Tananbaum· per SEC Form D
BiotechCambridge, US
Alan Ezekowitz(Director)James Collins(Director)Mark Levin(Director)Robert Gould(Executive Officer, Director)James Geraghty(Director)
Board seatJames Tananbaum· per SEC Form D
Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions.
BiotechDigital HealthHealthtechMedical Devices<UNKNOWN>
Matthew Rabinowitz(Co-founder & Executive Chairman)
Next-generation genetic sequencing using microfluidics for sequencing and molecular diagnostics
Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.
BiotechHealthtechMedical DevicesWayne, US
Neal Walker(Executive Officer, Director)Joseph Monahan(Executive Officer)Hugh Davis(Executive Officer, Director)James Loerop(Executive Officer)Kevin Balthaser(Executive Officer)Kamil Ali-Jackson(Executive Officer)
Adaptive Biotechnologies decodes the genetic patterns of the adaptive immune system to develop clinical products for diagnosing and treating disease.
BiotechDigital HealthHealthtechMedical DevicesSeattle, US
Arnold Levine(Director)Chad Robins(Executive Officer, Director)Andris Zoltners(Director)Tom Willis(Director)Kathleen Determann(Executive Officer)Peter Neupert(Director)
BiotechMenlo Park, US
Nathan Hubbard(Executive Officer)Aya Jakobovits(Executive Officer, Director)Jonathan Silverstein(Director)Carl Gordon(Director)Florent Gros(Director)Erez Chimovits(Director)
Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration.
AI & Machine LearningBiotechHealthtechLongevityMedical DevicesSan Francisco, US
Arnon Rosenthal(Ph.D.)Carl Gordon(Director)Tillman Gerngross(Director)Terry McGuire(Director)
Allogene Therapeutics develops allogeneic CAR T cell therapies (AlloCAR T) for blood cancers, solid tumors, and autoimmune diseases, using off-the-shelf manufactured cell products rather than patient-derived autologous approaches.
BiotechHealthtechMedical Devices
ROBERT ABRAHAM(Director)OWEN WITTE(Director)DAVID BONDERMAN(Director)TODD SISITSKY(Director)JOSHUA A. KAZAM(Executive Officer, Director)DAVID M. TANEN(Executive Officer)
BiotechWarminster, US
Andrew Cheng(Director)Eric Venker(Director)William H. Collier(President and Chief Executive Officer)Gaston Picchio(Chief Development Officer)Michael J. McElhaugh(Chief Business Officer)Frank Torti(Chairman)
BiotechFremont, US
Annalisa Jenkins(Director)Mark Kaufmann(Executive Officer)Elizabeth Grammer(Executive Officer)Richard Rodgers(Director)Gordon Ringold(Director)Peter G. Schultz(Director)
Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.
BiotechDeep TechMedical DevicesCambridge, US
David R. Liu(Founder and Inventor)J. Keith Joung(Founder and Inventor)Feng Zhang(Founder and Inventor)CAROLE HO(Director)John Evans(Executive Officer, Director)MARK FISHMAN(Director)
BiotechBeijing
Chunhua Wang(Chief Operating Officer)Wei Gao(General Counsel)Alexander Y. Wu(Director)Zhenbo Su(Director)Hai Huang(Global Chief Commercial Officer)Kun Qian(Global Controller)
BiotechHampton, US
Herbert J. Conrad(Director)Anthony S. Marucci(Executive Officer, Director)Karen Shoos(Director)Richard van den Broek(Director)Larry Ellberger(Director)Avery W. Catlin(Executive Officer)
Cambridge, US
HealthtechBurlingame, US
Leiv Lea(Executive Officer)Elisha (Terry) P. Gould(Director)Peter Moldt(Director)Peter Thompson(Director)Richard A. Miller(Executive Officer, Director)
BiotechSan Diego, US
YunFei Zhu(Executive Officer)Steve Kaldor(Director)Mason Freeman(Director)Wendell Wierenga(Director)Richard Scott Struthers(Executive Officer, Director)Mahendra Shah(Director)
Denali Therapeutics develops therapeutics for neurodegenerative diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Carole Ho(Executive Officer)Vicki L. Sato(Director)Nancy A. Thornberry(Director)Peter S. Klein(Director)Marc Tessier-Lavigne(Director)Jay T. Flatley(Director)
Boulder, US
Kevin Koch(Executive Officer, Director)Peter Thompson(Director)Kenneth Harrison(Director)Jonathan Root(Director)Alan Russell(Director)
GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.
AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US
Joshua Ofman, MD, MSHS(Chief Executive Officer)Aaron Freidin(Executive Officer)Sarah Krevans(Director)Gregory Summe(Director)Josh Ofman(Executive Officer)Steve Mizell(Director)
Hinge Health builds a digital healthcare platform designed to help individuals manage musculoskeletal health and related conditions.
Digital HealthHealthtechMedical DevicesWellness & FitnessSan Francisco, US
Gabriel Mecklenburg(Executive Officer, Director)Daniel Perez(Executive Officer, Director)
Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.
BiotechDigital HealthHealthtechMedical Devices<UNKNOWN>, US
BiotechCambridge, US
Nessan Bermingham(Executive Officer, Director)Jose Rivera(Executive Officer)Carl Gordon(Director)Jean-Francois Formela(Director)John Leonard(Executive Officer, Director)Rachel Haurwitz(Director)
Antibodies to neutralize SARS-CoV-2 and related coronaviruses (NASDAQ: IVVD).
BiotechNewton, US
Peter Honig(Director)Barry E. Greene(Director)Stuart Poulton(Executive Officer)Michael Mano(Executive Officer)Reshma Rangwala(Executive Officer)Richard Paulson(Executive Officer, Director)
BiotechLexington, US
Jasbir S. Seehra(Executive Officer, Director)Julius Knowles(Director)Alon Lazarus(Director)Ohad Hammer(Director)Ran Nussbaum(Director)
Kura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.
BiotechDigital HealthMedical DevicesLa Jolla, US
HEIDI HENSON(Executive Officer)TROY WILSON(Executive Officer, Director)ANNETTE NORTH(Executive Officer)PINGDA REN(Executive Officer)YI LIU(Executive Officer)ANTONIO GUALBERTO(Executive Officer)
BiotechFort Washington, US
Fred Craves(Director)Rebecca Taub(Executive Officer, Director)Lionel Carnot(Director)
San Francisco, US
David Goeddel(Director)Mark Goldsmith(Director)Arthur T. Sands(Executive Officer, Director)Timothy Kutzkey(Executive Officer, Director)
Creating next generation precision medicines for patients with cancer and inflammatory diseases by targeting key signaling nodes.
BiotechCambridge, US
Valerie Odegard(Director)Jill Carroll(Director)Carl Gordon(Director)Jeffrey Leiden(Director)Charles Baum(Director)Gary D Glick(Executive Officer, Director)
BiotechSan Francisco, US
Cyrus L. Harmon, Ph.D.(Director)David C. Myles, Ph.D.(Executive Officer)Sean Bohen, M.D., Ph.D.(Executive Officer, Director)Naseem Zojwalla, M.D.(Executive Officer)Shane Kovacs(Executive Officer)David Myles(Executive Officer)
Improving patients' lives by accelerating development and commercialization of medicines that matter.
BiotechCambridge, US
Thomas Catinazzo(Executive Officer)Peter Rahmer(Executive Officer)Sekar Kathiresan(Director)Douglas S. Ingram(Director)Sanjiv K. Patel(Executive Officer, Director)Mark Murcko(Director)
BiotechRedwood City, US
Laurence Lasky(Director)Alexis Borisy(Director)Margaret Horn(Executive Officer)Michael Bonney(Director)Mark A. Goldsmith(Executive Officer, Director)Elizabeth Anderson(Director)
BiotechBoston, US
Edward T. Mathers(Director)David J. McGirr(Director)Jonathan Silverstein(Director)Keith Gottesdiener(Executive Officer, Director)David P. Meeker, M.D.(Director)Neil Exter(Director)
Seaport Therapeutics develops therapeutics and medicines.
BiotechMental HealthBoston, US
Daphne Zohar(Founder, CEO and Board Member)Michael Chen(Executive Officer)Lana Gladstein(Executive Officer)Antony Loebel(Executive Officer)Eric Green(Executive Officer)
BoardJames I. Healy(Director)
BiotechLondon
James Ede-Golightly(Director)Alistair Gray(Director)Craig Tooman(Executive Officer)Dave Lemus(Director)Giles Campion(Executive Officer)Romano Steven(Director)
BiotechCharlestown, US
Lynne Sullivan(Director)Adam Koppel(Director)Stephen DiPalma(Executive Officer)Martin Freed(Director)Alexander (Bo) Cumbo(Executive Officer, Director)Paul Herizch(Executive Officer)
Tango Therapeutics develops genetically targeted medicines using synthetic lethality principles to treat specific tumors.
BiotechBoston, US
John Ketchum(Director)Barbara Weber(Executive Officer, Director)Malte Peters(Director)Kanishka Pothula(Director)Lesley Ann Calhoun(Director)Mace Rothenberg(Director)
Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients.
BiotechMedical DevicesNeedham, US
Robert WeinbergTIMOTHY BARBERICH(Director)ALISON LAWTON(Director)ERIC ROWINSKY(Director)BRUCE WENDEL(Director)GINA CONSYLMAN(Director)
Singapore
Remix Therapeutics develops RNA reprogramming technology to treat various diseases and disorders.
AI & Machine LearningBiotechWatertown, US
Peter Smith, PhD(Co-Founder, President and Chief Executive Officer)Peter Smith(Co-Founder, President and Chief Executive Officer)Robert Gagnon(Executive Officer)Matthew Patterson(Director)Kevin Bitterman(Director)Jeff Goater(Director)
Board seatMichael Rome· per SEC Form D
Browse all 223 investments with full details →
▶23 more tracked companies
SomaLogicSotera WirelessStepful, Inc.TassoTenSixteen BioTessera TherapeuticsThe Medicines CompanyTheseusThird Arc BioThymeThyme CareTurning Point TherapeuticsUniqureVaxcyte (Alumni)VeliaVenatorx PharmaceuticalsVerastem, Inc.Verona PharmaVitae PharmaceuticalsVoyager Therapeutics (Alumni)Xaira TherapeuticsXintheraZenefits
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Foresite Capital invest at?
- Foresite Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Foresite Capital focus on?
- Foresite Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Foresite Capital located?
- Foresite Capital is headquartered in Larkspur, US.
From the blog
visit blog ↗Foresite Capital has invested in healthcare innovations across diagnostics, urgent care delivery, and neuropsychiatric drug development, with a focus on companies addressing significant unmet patient needs through differentiated technologies and consumer-driven models. AI summary
Media · Podcasts & interviews
featuring the teamJim Tananbaum, Foresite Capital Founder on Healthcare & Life Sciences
Grace Gong · Jim Tananbaum
How AI Is Rewriting Drug Discovery and Biotech Investing | Jim Tananbaum of Foresite Capital
Nicholas Moran · Jim Tananbaum
Why Jim Tananbaum, Founder & CEO of Foresite Capital, is excited by the Element AVITI
Element Biosciences · Jim Tananbaum
Images
Co-investors · 29
RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
F-Prime Capital Partners is a venture capital firm whose team of scientists, engineers, physicians, operators, and investors supports companies in scaling and accelerating growth.
ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.
venBio is a life sciences venture capital firm that partners with industry leaders to develop novel therapeutics and technologies addressing unmet medical needs.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Aisling Capital is an investment firm focused on companies developing and commercializing innovative healthcare products, services, and technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
The Column Group (TCG) is a venture capital firm focused on building and backing biotechnology companies, applying an edge-to-edge investment model centered on company formation with capacity for long-term private and public capital support.
Menlo Ventures is a venture capital firm that backs transformative, early-stage technology companies reshaping how people live and work.
▶17 more co-investors
Flare Capital Partners5AM VenturesWestlake Village BioPartnersNew Enterprise Associates (NEA)First Round CapitalPontifax Venture CapitalSequoia CapitalBain Capital VenturesGeneral AtlanticWildcat Venture PartnersTorch CapitalMolten VenturesNorthpond VenturesDeerfield Management CompanyMaverick CapitalRecode VenturesCivilization Ventures Management, Llc
Firms observed investing alongside Foresite Capital, from public investor directories. Shared companies are the overlap with Foresite Capital's recorded portfolio.
Similar investors
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann. It invests internationally in transformative technology companies.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.